Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 11:30 AM EDTCompany ParticipantsMichael Bodner - Global ...
As the pulsed field ablation market heats up with competition from Boston Scientific, Medtronic, and Johnson & Johnson, Pulse Biosciences is positioning its nanosecond PFA technology as a ...
Maintain closer engagement with members that have substantial outstanding Fund credit but do not have a Fund-supported program or a staff-monitored program. By assessing these members’ capacity to ...
Ford is recalling 4,380,609 vehicles due to an issue with the Integrated Trailer Module (ITRM) that affects trailer brake lights and can impact the trailer brakes. The recall includes the F-150, F-250 ...
INTO LAW. SARAH. YEAH. AFTER PASSING IN THE HOUSE, THE BILL IS NOW HEADED TO THE SENATE. AND IF SIGNED INTO LAW, IT WOULD STRENGTHEN ENFORCEMENT FOR PROTECTION FROM ABUSE ORDERS AND VIOLATIONS WITH ...
Proposed Pennsylvania legislation would increase penalties for crimes committed while violating a protection from abuse order. Domestic violence prevention groups support the bills, citing an increase ...
In April, we reported on a study that raised alarms for safety issues with pulsed field ablation for atrial fibrillation. In this report, we follow up on subsequent developments for this technology.
Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its Volt PFA System to treat atrial fibrillation. The highly anticipated ...
Atrial fibrillation (AF or AFib) is one of the most common abnormal heart rhythms, affecting nearly 38 million people worldwide — a figure projected to nearly triple by 2030. Boston Scientific BSX ...
The European Space Agency (ESA) has completed the service module for NASA's Orion spaceship, which is meant to take the nearly cancelled Artemis 4 mission to the moon. The module, which is supposed to ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced a series of major milestones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results